Pathophysiology of the optic neuropathy associated with Friedreich ataxia.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.121.11.1582PMID 14609915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The expanded clinical spectrum of deferoxamine retinopathy.

  2002cited by this paper
• Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

  2002cited by this paper
• Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells.

  2002cited by this paper
• Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

  2001cited by this paper
• Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage.

  2001cited by this paper
• Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.

  2001cited by this paper
• Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits

  2001cited by this paper
• Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron.

  2001cited by this paper
• Mitochondrial Control of Iron Homeostasis

  2001cited by this paper
• Sensitivity of FRDA Lymphoblasts to Salts of Transition Metal Ions

  2000cited by this paper
• Differential susceptibility of retinal ganglion cells to reactive oxygen species.

  2000cited by this paper
• Desferrioxamine (DFO) conjugated with starch decreases NAD redox potential of intact red blood cells (RBC): Evidence for DFO as an extracellular inducer of oxidant stress in RBC

  2000cited by this paper
• Frataxin activates mitochondrial energy conversion and oxidative phosphorylation.

  2000cited by this paper
• Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation.

  2000cited by this paper
• Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

  1999cited by this paper
• Markedly different course of Friedreich’s ataxia in sib pairs with similar GAA repeat expansions in the frataxin gene

  1999cited by this paper
• The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.

  1999cited by this paper
• The Yeast Frataxin Homologue Mediates Mitochondrial Iron Efflux

  1999cited by this paper
• The Hereditary Ataxias

  1998cited by this paper
• The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure.

  1998cited by this paper
• Phenotypic variability in friedreich ataxia: Role of the associated GAA triplet repeat expansion

  1997cited by this paper
• Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.

  1997cited by this paper
• Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue

  1997cited by this paper
• Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia.

  1997cited by this paper
• Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion

  1996cited by this paper
• Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction.

  1996cited by this paper
• Visual involvement in Friedreich's ataxia: PERG and VEP study.

  1988cited by this paper
• The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients.

  1980cited by this paper
• The hereditary ataxias.

  1976cited by this paper

• Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application

  2023cites this paper
• Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering.

  2023cites this paper
• Retinal and Visual Pathways Involvement in Carriers of Friedreich’s Ataxia

  2022cites this paper
• Rare occurrence of severe blindness and deafness in Friedreich ataxia: a case report

  2021cites this paper
• Longitudinal Assessment Using Optical Coherence Tomography in Patients with Friedreich’s Ataxia

  2021cites this paper
• Neuro-Ophthalmological Findings in Friedreich’s Ataxia

  2021cites this paper
• Multimodal Imaging in Ocular Siderosis

  2020cites this paper
• Ocular Involvement in Friedreich Ataxia Patients and Its Relationship with Neurological Disability, a Follow-Up Study

  2020cites this paper
• Peripapillary retinal nerve fibre layer thickness in Friedreich's ataxia: a biomarker for trials?

  2019cites this paper
• Visual Loss

  2019cites this paper
• Increased Frataxin Levels Protect Retinal Ganglion Cells After Acute Ischemia/Reperfusion in the Mouse Retina In Vivo.

  2016cites this paper
• Optical Coherence Tomography in Neurodegenerative Disorders

  2016cites this paper
• Characterization of the retinal pigment epithelium in Friedreich ataxia

  2015cites this paper
• Optical Coherence Tomography and Visual Field Findings in Patients With Friedreich Ataxia

  2014cites this paper
• Iron, zinc, and copper in retinal physiology and disease.

  2013cites this paper
• Ophthalmic features of Friedreich ataxia

  2011cites this paper
• Atypical, perhaps under-recognized? An unusual phenotype of Friedreich ataxia

  2010cites this paper
• Iron metabolism in the eye: a review.

  2009cites this paper
• Relapsing peripheral facial palsy: An unusual early sign of Friedreich ataxia

  2008cites this paper
• Optic atrophies in metabolic disorders.

  2005cites this paper